# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-049423
Filing Date
2020-11-02
Accepted
2020-11-02 06:32:07
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | apls-10q_20200930.htm iXBRL | 10-Q | 3014615
2 | EX-10.2 | apls-ex102_46.htm | EX-10.2 | 5290
3 | EX-31.1 | apls-ex311_6.htm | EX-31.1 | 18440
4 | EX-31.2 | apls-ex312_9.htm | EX-31.2 | 17555
5 | EX-32.1 | apls-ex321_7.htm | EX-32.1 | 8566
6 | EX-32.2 | apls-ex322_8.htm | EX-32.2 | 8580
| Complete submission text file | 0001564590-20-049423.txt |  | 8683637

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | apls-20200930.xsd | EX-101.SCH | 52315
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | apls-20200930_cal.xml | EX-101.CAL | 45712
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | apls-20200930_def.xml | EX-101.DEF | 170418
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | apls-20200930_lab.xml | EX-101.LAB | 386399
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | apls-20200930_pre.xml | EX-101.PRE | 306716
12 | EXTRACTED XBRL INSTANCE DOCUMENT | apls-10q_20200930_htm.xml | XML | 1438481

Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 201278914
SIC: 2834 Pharmaceutical Preparations